• Fluconazole: A Benchmark Fungal Cytochrome P450 Inhibitor

  2026-04-30

  Fluconazole is a triazole-based antifungal and a key fungal cytochrome P450 enzyme 14α-demethylase inhibitor. It is widely used for ergosterol biosynthesis inhibition and antifungal susceptibility testing in research. This article details its mechanism, benchmarks, and critical application boundaries.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry:

  2026-04-30

  Wang et al. (2018) establish that clathrin-mediated endocytosis, requiring both dynamin and endosomal acidification, is essential for the cellular entry of type III grass carp reovirus (GCRV104). The study also demonstrates that the protein kinase C inhibitor Rottlerin significantly impedes viral entry and replication, providing new mechanistic understanding and experimental tools for dissecting virus-host interactions.

• Ibrexafungerp Efficacy in Fluconazole-Resistant Candida auri

  2026-04-29

  Wiederhold et al. demonstrate that ibrexafungerp, a first-in-class triterpenoid, displays potent in vitro and in vivo activity against fluconazole-resistant Candida auris. The study provides crucial comparative evidence on antifungal efficacy and highlights ongoing challenges in treating multidrug-resistant invasive candidiasis.

• Biomimetic Microparticles Disrupt Tumor pH for Chemo-Immunot

  2026-04-29

  This study presents a biomimetic microparticle system that simultaneously disrupts intracellular and extracellular pH homeostasis in tumor cells by co-delivering syrosingopine and a doxorubicin prodrug. The approach enhances chemotherapeutic and immunotherapeutic efficacy, addressing metabolic adaptations and immune suppression in the tumor microenvironment.

• Ferrostatin-1 (Fer-1): Precision Tools for Ferroptosis in De

  2026-04-28

  Explore how Ferrostatin-1 (Fer-1) empowers advanced ferroptosis assays in developmental and disease models. This article uniquely bridges mechanistic insights with practical protocol guidance for oxidative lipid damage inhibition research.

• Omicron KP.3 RBD mRNA Vaccine: Broad Neutralization in Mice

  2026-04-28

  The referenced study introduces an mRNA vaccine encoding the Omicron KP.3 RBD, demonstrating broad neutralization against multiple SARS-CoV-2 Omicron subvariants and robust protection in a mouse model. This work highlights the value of nucleoside-modified mRNA and supports ongoing efforts to optimize mRNA vaccine platforms for evolving viral threats.

• Griseofulvin's Role in Aneugenicity Assays: Mechanisms and R

  2026-04-27

  Explore how Griseofulvin, a microtubule associated inhibitor, enables precision in aneugenicity assays and antifungal drug research. This article uniquely analyzes assay decision-making and mechanistic insights beyond standard antifungal perspectives.

• Mifepristone (RU486): Data-Driven Solutions for Cell Assays

  2026-04-27

  This article addresses real-world laboratory challenges in cell viability, proliferation, and hormone signaling assays, focusing on the validated performance of Mifepristone (RU486) (SKU B1511). With evidence-based answers and scenario-driven guidance, researchers can optimize experimental rigor and reproducibility using APExBIO’s high-purity reagent.

• PP2A-Mediated Autophagy Drives Candida albicans Biofilm Resi

  2026-04-26

  This study uncovers how protein phosphatase 2A (PP2A) modulates biofilm formation and drug resistance in Candida albicans by inducing autophagy via ATG protein phosphorylation. The findings highlight a critical regulatory node influencing antifungal susceptibility and suggest new avenues for targeting biofilm-associated resistance.

• Fluconazole as a Probe for Autophagy-Driven Antifungal Resis

  2026-04-25

  Explore how Fluconazole, a fungal cytochrome P450 enzyme 14α-demethylase inhibitor, empowers advanced research into autophagy-mediated drug resistance in Candida albicans. This article uniquely bridges mechanistic insights with practical protocol guidance for antifungal susceptibility testing.

• Mechanistic Blueprint of ZAK Activation at Collided Ribosome

  2026-04-24

  This study employs cryo-EM and biochemical analyses to elucidate the structural and mechanistic determinants of ZAK kinase activation during ribosome collisions, a key trigger of the ribotoxic stress response. The findings clarify how RACK1 scaffolding and SAM domain dimerization enable collision-specific ZAK activation, with implications for understanding cellular stress signaling and kinase regulation.

• Ertugliflozin Modulates Insulin Signaling and Tau in Alzheim

  2026-04-24

  This study demonstrates that Ertugliflozin (PF-04971729), a selective SGLT2 inhibitor, can attenuate cognitive deficits and mitigate tau hyperphosphorylation in a rat model of Alzheimer’s disease induced by brain insulin resistance. The findings suggest a novel neuroprotective role for SGLT2 inhibition, linking diabetes mellitus research with neurodegenerative disease mechanisms.

• CRTC-CREB Axis Protects Against Proteotoxic Stress via Prote

  2026-04-23

  This study uncovers how the CRTC-CREB axis acts as a transcriptional sensor to counteract proteotoxic stress in Drosophila, particularly in response to proteasome inhibition. The findings illuminate redox-dependent JNK signaling as a mediator of CREB activation and highlight potential therapeutic avenues for aging and protein aggregation diseases.

• Lipo3K Transfection Reagent: High-Efficiency Nucleic Acid De

  2026-04-23

  Lipo3K Transfection Reagent from APExBIO delivers robust gene expression and gene silencing even in difficult-to-transfect cells, with minimal cytotoxicity. This workflow-centric guide translates recent research and hands-on troubleshooting into actionable protocols for gene expression and RNA interference studies.

• Engineering RNA for Immunity: Beyond High-Yield Synthesis

  2026-04-22

  This thought-leadership article bridges mechanistic insights into viral immune evasion with actionable guidance for translational researchers. By referencing the latest findings on SARS-CoV-2 N protein-mediated antagonism of the GADD34–IRF3 axis, it demonstrates the vital role of precise, high-yield in vitro RNA synthesis—enabled by the HyperScribe™ SP6 High Yield RNA Synthesis Kit—in dissecting innate immune pathways, developing RNA vaccines, and advancing next-generation molecular research. The article uniquely integrates recent literature, advanced protocol recommendations, and a forward-looking vision for RNA-centric discovery.

16550 records 1/1104 page Next 12345 下5页 Last page